Side effects
The likelihood of experiencing side effects is affected by your overall health as well as the medications you are taking. The most frequent side effects of Cozac include: allergic reactions (wheezing, difficulty breathing or dizziness, swelling of the eyelids, face, lips or throat, rash, convulsions); insomnia; dizziness; sleepiness; headache; diarrhea; feeling sick; dry mouth; fatigue; sore throat; depression; anxiety; agitation; nervousness; decreased sexual interest; teeth grinding; numbness and tingling; shaking; muscle tense; abnormal taste; lack of attention;
Interactions
If you are taking any of the following medications, talk to your doctor before taking Cozac: fentanyl, anesthetics, tricyclic antidepressants (imipramine), lithium (for mania and depression), diazepam (a sedative), amino acid tryptophan (for depression), tolbutamide (for diabetes), cimetidine (for ulcers), non-steroidal anti-inflammatory drugs (NSAIDs), d. John's Wort, flecainide, propafenone, verapamil, diltiazem, medications to control heartbeat, medications to treat fungal infections (ketoconazole, itraconazole, posaconazole, voriconazole, fluconazole), and medications to stop nausea and vomiting following surgery or chemotherapy (aprepitant).
Contraindications
Until your doctor determines if this medication is right for you, Cozac is not advised for use by women who are pregnant, planning a pregnancy, or who are nursing a baby. Only adults (those over the age of 18) may use cozaar. Do not drive or operate machinery while treatment with Cozac. If you have ever thought about hurting or killing yourself, do not take Cozac. If you have serotonin syndrome, low sodium levels in your blood, liver disease, angle-closure glaucoma, or a family history of it, you should not take Cozac. If you have ever had a bleeding disorder or have ever taken an anticoagulant (like warfarin or acetylsalicylic acid), you should not take Cozac. Only those with obsessive compulsive disorder (OCD) who are 8 to 18 years old can receive treatment with it.
